Skip to main content

Table 3 Pooled HRs of overall survival of patients with increased SNHG5 expression

From: An increase in SNHG5 expression is associated with poor cancer prognosis, according to a meta-analysis

Subgroup analysis

Number of studies

Number of patients

Pooled HR(95%CI)

I2(%)

P-value

Model

Fix effect model

Random effect model

OS

7

425

1.33 (1.00–1.77)

1.90 (0.87–4.15)

85

 < 0.00001

Random

Tumor type

 Digestive system

4

262

0.97 (0.67–1.41)

1.45 (0.42–4.96)

90

 < 0.00001

Random

 Non-digestive system

3

163

2.06 (1.32–3,20)

2.54 (1.18–5.48)

53

0.12

Random

Analysis method

 Univariate analysis

5

327

1.02 (0.75–1.40)

1.31 (0.58–2.99)

84

 < 0.0001

Random

 Multivariate analysis

2

98

4.84 (2.42–9.70)

4.84 (2.42–9.70)

0

0.97

Fixed

Cut-off value

 Mean

1

67

2.82 (1.13–7.04)

2.82 (1.13–7.04)

–

–

–

 Median

6

358

1.23 (0.91–1.65)

1.79 (0.74–4.30)

87

 < 0.00001

Random

HR statistics

 Paper

2

98

4.84 (2.42–9.70)

4.84 (2.42–9.70)

0

0.97

Fixed

 Survival curve

5

327

1.02 (0.75–1.40)

1.31 (0.58–2.99)

84

 < 0.0001

Random

Number of patients

 Not less than 60

4

295

0.93 (0.68–1.29)

0.99 (0.45–2.18)

83

0.0006

Random

 Less than 60

3

130

5.23 (2.78–9.83)

5.23 (2.78–9.83)

0

0.87

Fixed

Follow-up (month)

 Not less than 60 month

4

295

1.11 (0.76–1.62)

1.19 (0.42–3.42)

86

0.0008

Random

 Less than 60 month

3

130

1.70 (1.09–2.63)

2.95 (0.75–11.64)

87

 < 0.0001

Random

 DFS

1

48

3.690 (1.229–11.082)

3.690 (1.229–11.082)

–

–

–

  1. The results were performed by the software of Revman version 5.4
  2. OS: overall survival; Random: Random effects; Fixed: Fixed effects; directly: HR was extracted directly from the primary articles; indirectly: HR was extracted indirectly from the primary articles; CI confidence interval; I2: I-square